Literature DB >> 17910086

Genetic mechanisms involved in the phenotype of Down syndrome.

David Patterson1.   

Abstract

Down syndrome (DS) is the most common genetic cause of significant intellectual disability in the human population, occurring in roughly 1 in 700 live births. The ultimate cause of DS is trisomy of all or part of the set of genes located on chromosome 21. How this trisomy leads to the phenotype of DS is unclear. The completion of the DNA sequencing and annotation of the long arm of chromosome 21 was a critical step towards understanding the genetics of the phenotype. However, annotation of the chromosome continues and the functions of many genes on chromosome 21 remain uncertain. Recent findings about the structure of the human genome and of chromosome 21, in particular, and studies on mechanisms of gene regulation indicate that various genetic mechanisms may be contributors to the phenotype of DS and to the variability of the phenotype. These include variability of gene expression, the activity of transcription factors both encoded on chromosome 21 and encoded elsewhere in the genome, copy number polymorphisms, the function of conserved nongenic regions, microRNA activities, RNA editing, and perhaps DNA methylation. In this manuscript, we describe current knowledge about these genetic complexities and their likely importance in the context of DS. We identify gaps in current knowledge and suggest priorities to fill these gaps. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17910086     DOI: 10.1002/mrdd.20162

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  18 in total

1.  The relationship between craniofacial development and hypodontia in patients with Down syndrome.

Authors:  D J F van Marrewijk; M A E van Stiphout; W Reuland-Bosma; E M Bronkhorst; E M Ongkosuwito
Journal:  Eur J Orthod       Date:  2015-08-14       Impact factor: 3.075

2.  Phenotypic consequences of aneuploidy in Arabidopsis thaliana.

Authors:  Isabelle M Henry; Brian P Dilkes; Eric S Miller; Diana Burkart-Waco; Luca Comai
Journal:  Genetics       Date:  2010-09-27       Impact factor: 4.562

3.  Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes.

Authors:  Mireia Vilardell; Axel Rasche; Anja Thormann; Elisabeth Maschke-Dutz; Luis A Pérez-Jurado; Hans Lehrach; Ralf Herwig
Journal:  BMC Genomics       Date:  2011-05-11       Impact factor: 3.969

4.  Peer-related social competence of young children with Down syndrome.

Authors:  Michael J Guralnick; Robert T Connor; L Clark Johnson
Journal:  Am J Intellect Dev Disabil       Date:  2011-01

Review 5.  Sleep measurement and monitoring in children with Down syndrome: a review of the literature, 1960-2010.

Authors:  Shervin S Churchill; Gail M Kieckhefer; Carol A Landis; Teresa M Ward
Journal:  Sleep Med Rev       Date:  2012-03-10       Impact factor: 11.609

6.  Subgingival microbiota in adult Down syndrome periodontitis.

Authors:  A Khocht; T Yaskell; M Janal; B F Turner; T E Rams; A D Haffajee; S S Socransky
Journal:  J Periodontal Res       Date:  2012-01-03       Impact factor: 4.419

7.  Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects.

Authors:  S B Freeman; C P Torfs; P A Romitti; M H Royle; C Druschel; C A Hobbs; S L Sherman
Journal:  Clin Genet       Date:  2008-11-17       Impact factor: 4.438

Review 8.  Molecular genetic analysis of Down syndrome.

Authors:  David Patterson
Journal:  Hum Genet       Date:  2009-06-13       Impact factor: 4.132

9.  Mutations in the Chinese hamster ovary cell GART gene of de novo purine synthesis.

Authors:  Aaron J Knox; Christine Graham; John Bleskan; Gary Brodsky; David Patterson
Journal:  Gene       Date:  2008-10-21       Impact factor: 3.688

10.  Relationship between Apgar scores and long-term cognitive outcomes in individuals with Down syndrome.

Authors:  Laura Del Hoyo Soriano; Tracie C Rosser; Debra R Hamilton; Danielle J Harvey; Leonard Abbeduto; Stephanie L Sherman
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.